Ashiq Mubarack

Item: Ashiq Mubarack
Rating: 0.89
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.89)

# 3,798

Out of 4,898 analysts

Total ratings

66.67%

Success rate

-17.26%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$6 → $5	$0.34	+1,357.73%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$3.22	+148.45%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $6 → $5

Current: $0.34

Upside: +1,357.73%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $3.22

Upside: +148.45%